Generate:Biomedicines

Lila Sciences claims that three of its scientists designed a new CAR-T cancer therapy candidate in months, with preclinical results beating a leading therapy already used in patients, according to an …

Nvidia's venture arm NVentures disclosed a $10.4 million stake in Generate:Biomedicines, an AI-driven drug discovery company with a Phase 3 asthma trial and FDA Fast Track oncology candidates. The inv…